DB
CRBU icon

Dmitry Balyasny’s Caribou Biosciences CRBU Stock Holding History

Dmitry Balyasny’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-52,419
Closed -$86K – 2795
2024
Q2 		$86K Sell
52,419
-110,264
-68% -$352K ﹤0.01% 2410
2024
Q1 		$836K Buy
+162,683
New +$1M ﹤0.01% 1867
2022
Q2 		– Sell
-11,812
Closed -$108K – 2812
2022
Q1 		$108K Buy
+11,812
New +$124K ﹤0.01% 2130

Other funds holding CRBU

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
EWM
Elmwood Wealth Management Berkeley, California $400M AUM 17.81% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

Dmitry Balyasny's CRBU Position: Q3 2024 in Review

Dmitry Balyasny sold out of Caribou Biosciences (CRBU) in Q3 2024, closing a stake of 52,419 shares — an estimated $86K sold.

Dmitry Balyasny first reported a position in CRBU in Q1 2022 and held it in 3 quarters. The position peaked at $836K in Q1 2024. 129 funds tracked by Wall St. Rank hold CRBU as of Q3 2024.

  • Dmitry Balyasny reported no remaining Caribou Biosciences position as of Q3 2024 after selling out during the quarter.
  • Dmitry Balyasny sold 52,419 Caribou Biosciences shares in Q3 2024, an estimated $86K.
  • Dmitry Balyasny first reported a position in Caribou Biosciences in Q1 2022 and held it in 3 quarters.
  • Dmitry Balyasny's Caribou Biosciences position peaked at $836K in Q1 2024.
  • 129 funds tracked by Wall St. Rank held Caribou Biosciences as of Q3 2024.

Based on Balyasny Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.